Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Prueba de una aplicación móvil de salud para mejorar la prevención del VIH y el tratamiento del consumo de sustancias entre mujeres involucradas en el sistema carcelario (PA-Links)

28 de septiembre de 2026 actualizado por: Sarah Bass, Temple University

Desarrollo y Prueba Piloto de una Aplicación de Salud Móvil para Mejorar el Acceso a los Servicios de Prevención del VIH y Tratamiento del Consumo de Sustancias entre Mujeres Involucradas en el Sistema Carcelario

Women involved in the carceral system (WICS) are at higher risk for both HIV and substance use than the general public. WICS are also more likely to engage in behaviors both before and after release that put them at risk for HIV and for overdose, due to opioid use. Despite these risk factors, WICS are less likely to be aware of, use, or adhere to pre-exposure prophylaxis (PrEP) and have less access to medications for opioid use disorder (MOUD). The primary goal of the proposed research is to pilot test a systematically developed PrEP and MOUD uptake intervention for WICS using contextually relevant messages developed through novel formative research methods and embedded in a web-based application in a rigorous research design. The investigators will then test this approach (called PA-LINKS) in a pilot randomized trial with women who have recently been incarcerated in Philadelphia in partnership with Philadelphia FIGHT, a federally qualified health center, for promise of efficacy, and to assess feasibility and acceptability.

Descripción general del estudio

Descripción detallada

The primary goal of the proposed research is to pilot test a systematically developed intervention for women who have been recently incarcerated to engage with pre-exposure prophalaxis (PrEP) and medication for opioid use disorder (MOUD) to prevent HIV infection and overdose. The intervention will use contextually relevant messages developed through novel formative research methods and be embedded in a web-based application called PA Links. The investigators will then test this approach in a pilot randomized trial with women who have recently been incarcerated. The purpose is to enhance communication in an existing post-release navigation model embedded in a community-based health services organization in Pennsylvania (Philadelphia FIGHT) to increase PrEP and MOUD uptake.

The app is meant to enhance communication among navigators, patients, and providers, as well as provide easy communication channels among participants for peer support. We will examine the feasibility/acceptability of the intervention with more traditional navigation support and examine preliminary data regarding its potential efficacy in engaging women in PrEP and MOUD.

For the pilot test, we will: 1. Conduct a pilot test with women who have recently been incarcerated (n=60) in Philadelphia randomized to an "Enhanced" intervention that includes patient navigation with the PA-Links web-based app + navigation, compared to a "Basic" intervention that includes existing navigation. To assess promise of efficacy, we will compare linkage to PrEP and MOUD (primary outcomes) during the three-month intervention at immediate post and 3-month follow-up and assess self-reported knowledge and attitudes. Qualitative exit interviews will inform feasibility and acceptability.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

74

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Sarah Bass, MPH, PhD
  • Número de teléfono: 215-204-0377
  • Correo electrónico: sbass@temple.edu

Copia de seguridad de contactos de estudio

  • Nombre: Emily F Dauria, PhD
  • Número de teléfono: 412-383-0732
  • Correo electrónico: efd16@pitt.edu

Ubicaciones de estudio

    • Pennsylvania
      • Philadelphia, Pennsylvania, Estados Unidos, 19122
        • Temple University
        • Contacto:
          • Sarah Bass, MPH, PhD
          • Número de teléfono: 2152040377
          • Correo electrónico: sbass@temple.edu
        • Contacto:
        • Investigador principal:
          • Sarah Bass, MPH

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Femenino

Descripción

Inclusion Criteria:

  • 18 of years of age or older
  • Self-identified woman
  • Previous experience (past six months) with the carceral system (jail, prison, on parole or under supervision)
  • Speaks and reads English
  • Self-reported negative HIV status
  • Indicates at least one HIV risk (i.e. any of the following in the past 6 months or in the six months prior to the most recent incarceration that call for consideration of PrEP as per the CDC risk indices: have engaged in condomless sex; have an HIV-positive sex partner; have had an STI; have had multiple [>6] partners; have engaged in transactional sex; have injected drugs, shared injection or drug use preparation equipment, or have been enrolled in opiate substitution therapy because of IDU; previous overdose)
  • Self-report using opioids in the past six months or six months prior to the most recent incarceration (prescription or not) OR self-report using medications for opioid use disorder in the past year.
  • Have access to the internet through some device - smart phone, computer or tablet (personal or at community location such as library or organization)

Exclusion Criteria:

  • Under 18 years old
  • Does not read or speak English
  • Does not identify as a woman
  • Has been diagnosed with HIV
  • Does not have previous experience with the criminal legal system within the last 6 months
  • Does not have HIV risk in last six months or six months prior to being incarcerated
  • Has not used opioids in past six months or six months prior to being incarcerated or MOUD in last year
  • Does not have access to internet
  • Cannot provide informed consent

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Control Arm

For those participants randomized to the "Basic" arm of the intervention, standard of care navigation already provided by Philadelphia FIGHT will be provided, without the use of the PA Links application. Each participant will be assigned a navigator or care coordinator who will assist people by scheduling initial/first appointments, making appointment reminder calls, coordinating services, providing education, and facilitating communication among FIGHT departments. Navigation occurs from initial patient contact until the patient has their first visit. Then a care coordinator is assigned, who assists patients in overcoming ongoing barriers to care and doing similar tasks as the navigators after the first visit. Participants in the basic arm will thus receive all the services any other patient at FIGHT would receive.

Experimental: Intervention Arm

Women in the intervention arm will receive all the same navigation services at FIGHT along with access to the PA Links web-based app. This app will enhance the usual care by: 1. Sending up the three resources every week based on a participant's interests and needs. 2. Providing one quiz a week. At the beginning of each week of the intervention, participants will receive a pop-up message when they log in with a true/false question. 3. Sending at least two supportive messages a week. 4. Posting reminders and messages from navigators about appointments, medication use, or for other issues. 5. Being able to interact with other participants via an embedded communication widget.

The PA Links application is a web-based application (meaning it does not have to be downloaded to a smart phone and can be accessed via a URL link from any device connected to the Internet). This design ensures broader access and avoids excluding individuals without smartphones. This was developed along with our technology partner Nurelm (https://nurelm.com/).

Women randomized to this arm of the intervention will go through an onboarding session to assist them in creating a unique login username and password to the PA Links system (see onboarding document attached). Only those with a registered username and password can access and use the PA Links system and Nurelm will not be able to access the application after it is "live" for the pilot RCT. The application will be housed on the AWS server, which also does not have access to data or information in the app.

Otros nombres:
  • Enlaces PA

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Pre-exposure Prophylaxis (PrEP) linkage
Periodo de tiempo: Immediate post intervention (3 months)

Assess via medical record whether participant has been linked to PrEP services. Yes/No

Immediate post intervention (3 months)
Medications for Opioid Use Disorder (MOUD) Linkage
Periodo de tiempo: Immediate post intervention (3 months)

Assess via medical record whether participant has been linked to MOUD services. Yes/No

Immediate post intervention (3 months)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Engagement with intervention
Periodo de tiempo: Immediate post intervention (3 months)

Number and types of contact with navigator. Gotten from app data and EMR navigator reports

Immediate post intervention (3 months)
Usability of PA-Links
Periodo de tiempo: Immediate post intervention (3 months)

User logs on what parts of application were used most; Survey questions asking which parts of app they used, yes/no.

Immediate post intervention (3 months)
PrEP treatment referral
Periodo de tiempo: Immediate post intervention (3 months); Three month post intervention follow-up (six months)

Accepted referral to PrEP. Data from FIGHT EMR. Yes/no

Immediate post intervention (3 months); Three month post intervention follow-up (six months)
MOUD treatment referral
Periodo de tiempo: Immediate post intervention (3 months); Three month post intervention follow-up (six months)

Accepted MOUD treatment referral. Data from FIGHT EMR. Yes/No

Immediate post intervention (3 months); Three month post intervention follow-up (six months)
HIV Risk
Periodo de tiempo: Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)

Self reported HIV behavior risk. Using the HIV Risk-Taking Behavior Scale. This scale is 11 items, assessing drug use and sexual behavior risk. Responses to each item are coded on a 6-point scale from 0 to 5, with higher values associated with more risky behaviors. Summary scores are obtained by adding up the ordinal values of responses obtained; a score of 0 would indicate no risky behaviors and a score of 55 would indicate maximal risky behaviors.

Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)
Overdose risk
Periodo de tiempo: Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)

Overdose risk and experience during intervention. Based on the Overdose Risk self-assessment, participants are asked about overdose risks answering yes or no. The more yes responses indicates a higher overdose risk.

Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)
PrEP perceptions
Periodo de tiempo: Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)

Perceptions of barriers and benefits to PrEP use. Study created scales - 12 statements on the benefits of using PrEP and 12 statements on barriers to using PrEP, answered on a zero -10 scale. Higher numbers mean higher agreement with the statement. These will be compared at the time points to assess if there is an increase in perceived benefits and a decrease in perceived barriers.

Baseline, before intervention begins; Immediate post intervention (3 months); Three month post intervention follow-up (six months)
MOUD perceptions
Periodo de tiempo: Baseline before intervention begins; Immediate post intervention (3 months); Three month intervention followup (6 months)

Perceptions of barriers and benefits to MOUD use. Study created scales - 11 statements on the benefits of using MOUD and 10 statements on barriers to using MOUD, answered on a zero -10 scale. Higher numbers mean higher agreement with the statement. These will be compared at the time points to assess if there is an increase in perceived benefits and a decrease in perceived barriers.

Baseline before intervention begins; Immediate post intervention (3 months); Three month intervention followup (6 months)
Time to Linkage of PrEP
Periodo de tiempo: Immediate post intervention (3 months); Three month post intervention follow-up (six months)

Time in months from navigator first contact to linkage to PrEP. EMR data from FIGHT.

Immediate post intervention (3 months); Three month post intervention follow-up (six months)
Receipt of prescription of PrEP
Periodo de tiempo: Immediate post intervention (3 months); Three month post intervention follow-up (six months)

Receipt of prescription of PrEP. EMR data from FIGHT. Yes/no

Immediate post intervention (3 months); Three month post intervention follow-up (six months)
Filling of PrEP prescription
Periodo de tiempo: Immediate post intervention (3 months); Three month post intervention follow-up (six months)

If PrEP prescription was filled. EMR data from FIGHT. Yes/No

Immediate post intervention (3 months); Three month post intervention follow-up (six months)
PrEP adherence
Periodo de tiempo: Immediate post intervention (3 months); 3 months intervention follow up (6 months)

Assess if participant is being adherent to PrEP based on FIGHT EMR data. Could be physician notes or blood work results, if taken. Yes/No

Immediate post intervention (3 months); 3 months intervention follow up (6 months)
PrEP knowledge
Periodo de tiempo: Baseline; Immediate intervention post-test (3 months); 3 month intervention follow-up (6 months)

True/False statements about PrEP. Five statements about PrEP. A composite score based on the number of correct answers will be assessed and compared across timepoints.

Baseline; Immediate intervention post-test (3 months); 3 month intervention follow-up (6 months)
Time to MOUD Linkage
Periodo de tiempo: Immediate post intervention (3 months); Three month post intervention follow-up (six months)

Time in months from navigator first contact to linkage to MOUD. EMR data from FIGHT.

Immediate post intervention (3 months); Three month post intervention follow-up (six months)
Receipt of MOUD Prescription
Periodo de tiempo: Immediate post intervention (3 months); 3 month post intervention follow-up (6 months)

Receipt of MOUD prescription. EMR data from FIGHT. Yes/no

Immediate post intervention (3 months); 3 month post intervention follow-up (6 months)
Filling of MOUD prescription
Periodo de tiempo: Immediate post intervention (3 months); 3 months intervention follow up (6 months)

Filling of MOUD prescription. EMR data from FIGHT. Yes/no

Immediate post intervention (3 months); 3 months intervention follow up (6 months)
MOUD adherence
Periodo de tiempo: Immediate post intervention (3 months); 3 months intervention follow up (6 months)

Assess if participant in adherent to MOUD based on FIGHT EMR data. Could be from physician notes or blood work, if taken. Yes/No

Immediate post intervention (3 months); 3 months intervention follow up (6 months)
MOUD Knowledge
Periodo de tiempo: Baseline; Immediate intervention post -test (3 months); 3 month intervention follow-up (six months)

True/False statements about MOUD. Five statements about MOUD. A composite score based on the number of correct answers will be assessed and compared across timepoints.

Baseline; Immediate intervention post -test (3 months); 3 month intervention follow-up (six months)
Client Intervention Satisfaction
Periodo de tiempo: Immediate post intervention (3 months)

Assessed via survey using five items from the the Study Participant Feedback Questionnaire. Two items are yes/no answers. Yes answers indicate they agree they were informed about the study. Three questions are on a 0-4 scale, with a zero indicating they strongly disagree with the statement and a 4 that they strongly agree. Higher number answers indicate higher intervention satisfaction.

Immediate post intervention (3 months)
mHealth feasibility/satisfaction
Periodo de tiempo: Immediate post intervention (3 months)

Assessed using the mHealth App Usability Questionnaire (MAUQ). It is a 21 item scale, with 8 items that assess Ease of use and satisfaction; 6 items on system information arrangement, and 7 items on usefulness. All use a 1 to 7 scale, indicating amount of agreement with a 7 as strongly agree. Each individual item will be assessed and a composite score for each area will also be assessed.

Immediate post intervention (3 months)
Usability of mHealth app
Periodo de tiempo: Immediate post intervention (3 months)

Assessed using the Usability of e-health interventions scale. It consists of 10 items scored on a 1-5 scale, indicating level of agreement, with a 5 meaning they strongly agree with the statement. The higher the score, the more they agree that the app was usable.

Immediate post intervention (3 months)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

20 de octubre de 2026

Finalización primaria (Estimado)

30 de mayo de 2027

Finalización del estudio (Estimado)

30 de mayo de 2027

Fechas de registro del estudio

Enviado por primera vez

13 de febrero de 2026

Primero enviado que cumplió con los criterios de control de calidad

23 de febrero de 2026

Publicado por primera vez (Actual)

25 de febrero de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

29 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

28 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir